Results 91 to 100 of about 612,298 (206)
Clinical Pharmacology &Therapeutics, Volume 120, Issue 4, Page 1120-1128, October 2026.Postmarketing safety surveillance data identify safety issues not identified in preapproval clinical trials. We describe the frequency of new safety issues overall and by labeling section and the relationship of the most commonly added safety issues with the cumulative number of prescriptions dispensed via retail pharmacies.
Ellen Pinnow +14 more
wiley +1 more source
TOXIC EPIDERMAL NECROLYSIS (LYELL’S SYNDROME)
Журнал инфектологии, 2018 .
E. N. Kudelka +6 more
doaj +1 more source
HemaSphere, Volume 10, Issue 10, October 2026.Abstract UKALL14 (NCT01085617) T‐cell arm was a phase 3, randomized‐controlled trial. Adults aged 25–65 years were randomized 1:1 at entry to receive standard of care (SOC) or SOC + nelarabine 1.5 g/m2 (Days 1, 3, and 5) to be administered following second induction. The primary end‐point was event‐free survival (EFS).
Clare J. Rowntree +14 more
wiley +1 more source
A case report of toxic epidermal necrolysis associated with AZD-9291
, 2018 Jie Wang, XianYe Cheng, Yan Lu, BingRong Zhou Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, The People’s Republic of China Abstract: Epidermal growth factor receptor-tyrosine kinase ...
Cheng XY, Lu Y, Zhou BR, Wang J
core
Acta Anaesthesiologica Scandinavica, Volume 70, Issue 9, October 2026.ABSTRACT Background Meropenem and piperacillin/tazobactam are commonly used empirical antibiotics in critically ill adults with sepsis, but whether one is superior to the other is uncertain. Methods The Empirical Meropenem versus Piperacillin/Tazobactam for Adult Patients with Sepsis (EMPRESS) trial is an ongoing investigator‐initiated, randomised ...
Nick Frørup Meier +37 more
wiley +1 more source
INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol
BJU International, Volume 138, Issue 4, Page 607-619, October 2026.Background High‐risk non‐muscle‐invasive bladder cancer (HRNMIBC) has a variable prognosis, managed predominantly by local surgical resection and intravesical Bacillus Calmette–Guérin (BCG), or radical cystectomy (RC). Current treatments are poorly tolerated, have supply limitations and often fail to control the disease.
Ruby Lister‐Whelan +13 more
wiley +1 more source
Contact Dermatitis, Volume 95, Issue 4, Page 349-357, October 2026.ABSTRACT Drug hypersensitivity reactions (DHRs) are common in children and are diagnostically challenging, with cutaneous manifestations being the most common presentation. Patch testing (PT) is a well‐established tool for investigating delayed T‐cell‐mediated reactions and is widely used in patients with contact dermatitis.
Gabriele Simonetti +7 more
wiley +1 more source
Results of treatment in our patients with toxic epidermal necrolysis [PDF]
, 2014 Objective: Toxic epidermal necrolysis is a rare disease that has very high mortality and morbidity. Despite the high mortality rate of the disease, treatment is still controversial today.
Ozturk, Fadil +5 more
core +1 more source
Toxic epidermal necrolysis: A review
Journal of the American Academy of Dermatology, 1991 This article reviews the many facets of toxic epidermal necrolysis. Emphasis is placed on the importance of early diagnosis, burn unit placement, supportive care, and avoidance of systemic steroids. Discussion also includes other therapeutic options and the pathophysiology of the disease.
From the College of Pharmacy, the Division of Dermatology and Cutaneous Surgery ( host institution ) +4 more
openaire +3 more sources